T2 Biosystems Reports Granting of Inducement Award Read more about T2 Biosystems Reports Granting of Inducement Award
T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus Read more about T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus
T2 Biosystems Appoints Industry Expert Aparna Ahuja, MD as Chief Medical Officer Read more about T2 Biosystems Appoints Industry Expert Aparna Ahuja, MD as Chief Medical Officer
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum Read more about T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum
Sepsis Alliance Elects T2 Biosystems CEO as Advisory Board Member Read more about Sepsis Alliance Elects T2 Biosystems CEO as Advisory Board Member
T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020 Read more about T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020
T2 Biosystems Announces BARDA Exercise of Contract Option 1 Valued at $10.5 Million Read more about T2 Biosystems Announces BARDA Exercise of Contract Option 1 Valued at $10.5 Million
T2 Biosystems to Participate in Sepsis Alliance Summit Read more about T2 Biosystems to Participate in Sepsis Alliance Summit
T2 Biosystems Announces CMS Approval of a New Technology Add-On Payment for the T2Bacteria® Panel for a Second Year Read more about T2 Biosystems Announces CMS Approval of a New Technology Add-On Payment for the T2Bacteria® Panel for a Second Year
T2 Biosystems Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test Read more about T2 Biosystems Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
